Viridian Therapeutics, Inc. (VRDN)

NCM – Цена в реальном времени. Валюта: USD

23.21

+0.24 (1.04%)

Рынок открыт: Aug 12, 2026, 12:38 PM EDT

22.98

+0.01 (0.04%)

Предыдущая сессия: Aug 11, 2026, 7:34 PM EDT

06.08.2026

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today reported recent business highlights and financial results for the second quarter ended June 30, 2026. “We are very encouraged by the early indications from our recent launch of Lumvoa as we start a new chapter for Viridian as a commercial-stage company,” said Steve.

Видео

No Data

There is no data to display

Пресс-релизы

06.08.2026

Viridian Therapeutics, Inc. (VRDN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Search stocks

Viridian Therapeutics, Inc. (VRDN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Видео

No Data

Пресс-релизы

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results